Combination of BAY 60-4552 and Vardenafil Exerts Proerectile Facilitator Effects in Rats With Cavernous Nerve Injury: A Proof of Concept Study for the Treatment of Phosphodiesterase Type 5 Inhibitor Failure
- 30 November 2011
- journal article
- Published by Elsevier BV in European Urology
- Vol. 60 (5), 1020-1026
- https://doi.org/10.1016/j.eururo.2011.07.052
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Summary of the Recommendations on Sexual Dysfunctions in MenThe Journal of Sexual Medicine, 2010
- Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature EjaculationEuropean Urology, 2010
- Phosphodiesterase Type 5 Inhibitors in Postprostatectomy Erectile Dysfunction: A Critical Analysis of the Basic Science Rationale and Clinical ApplicationEuropean Urology, 2009
- Expression and Distribution of Cyclic GMP-Dependent Protein Kinase-1 Isoforms in Human Penile Erectile TissueThe Journal of Sexual Medicine, 2008
- Interventions for sexual dysfunction following treatments for cancerPublished by Wiley ,2007
- Reciprocal Relationships Between Insulin Resistance and Endothelial DysfunctionCirculation, 2006
- TADALAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION FOLLOWING BILATERAL NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIALJournal of Urology, 2004
- Safety and Efficacy of Vardenafil for the Treatment of Men With Erectile Dysfunction After Radical Retropubic ProstatectomyJournal of Urology, 2003
- Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erectionProceedings of the National Academy of Sciences of the United States of America, 2002
- Erectile DysfunctionThe New England Journal of Medicine, 2000